Prevalence and incidence of hepatitis C in drug users: A review

Addictive Disorders and their Treatment

Volumn 7, Issue 4, 2008, Pages 190-198

  Abou Saleh, Mohammed T ^a,b   Foley, Suzanne ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Drug use; Hepatitis C; Incidence injecting; Prevalence

Indexed keywords

METHADONE;

COCAINE DEPENDENCE; HEPATITIS C; HEROIN DEPENDENCE; HUMAN; INCIDENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEROCONVERSION;

EID: 67649974107     PISSN: 15315754     EISSN: None     Source Type: Journal    
DOI: 10.1097/ADT.0b013e3181343614     Document Type: Review

References (46)

1. Choo QL, kuo G, Weiner AJ, et al. Isolation of a CDNA clone derived from a blood-borne non-a, non-b viral-hepatitis genome. Science. 1989;244: 359-362.
2. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-a, non-b-hepatitis. Science. 1989;244: 362-364.
3. Thomson BJ, Finch RG. Hepatitis C virus infection. Clin Microbiol Infect. 2005;11:86-94.
4. Pybus OG, Cochrane A, Holmes EC, et al. The hepatitis C virus epidemic among injecting drug users. Infection Genetics Evolution. 2005;5:131-139.
5. Best D, Noble A, Finch E, et al. Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment. BMJ. 1999;319:290-291.
6. Serfaty MA, Lawrie A, Smith B, et al. Risk factors and medical follow-up of drug users tested for hepatitis C: can the risk of transmission be reduced? Drug Alcohol Rev. 1997;16:339-347.
7. Judd A, Hickman M, Jones S, et al. Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study. BMJ. 2005;330:24-25.
8. Crofts N, Jolley D, Kaldor J, et al. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epidemiol Community Health. 1997;51:692-697.
9. Hunter GM, Stimson GV, Judd A, et al. Measuring injecting risk behaviour in the second decade of harm reduction: a survey of injecting drug users in England. Addiction. 2000;95:1351-1361.
10. Naplas B, Delaroques-Astagneau E, Bihan CL, et al. Medical practices regarding hepatitis C virus infection in Europe. J Viral Hepatitis. 1998; 15:131-141.
11. Aarons E, Grant P, Soldan K, et al. Failure to diagnose recent Hepatitis C virus infections in London injecting drug users. J Med Virol. 2004;73: 548-553.
12. Abou-Saleh MT, John CM. The efficacy of enhanced prevention counselling in the primary prevention of hepatitis C among injecting drug users, unpublished report for the Department of Health, 2003.
13. Abou-Saleh MT, Rice P, Foley S. the provision of hepatitis c testing, using the dried blood spot technique, to injecting drug users in specialised and community settings, Report to the National Treatment Agency for Substance Misuse, 2005.
14. Lamden KH, Kennedy N, Beeching NJ, et al. Hepatitis B and hepatitis C virus infections: risk factors among drug users in Northwest England. J Infection. 1998;37:260-269.
15. Roy KM, Goldberg D, Taylor V, et al. A method to detect the incidence of hepatitis C infection among injecting drug users in Glasgow 1993 to 1998. J Infection. 2001;43:200-205.
16. Goldberg D, McIntyre PG, Smith R, et al. Hepatitis C virus among high and low risk pregnant women in Dundee: unlinked anonymous testing. Br J Obstet Gynaecol. 2001;108:365-370.
17. Vandelli C, Renzo F, Romano L, et al. Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a ten-year prospective follow-up study. J Hepatol. 2004; 40:153.
18. MatheiC,BuntinxF,Van DammeP.Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review. J Viral Hepatitis. 2002;9: 157-173.
19. Muga R, Sanvisens A, Bolao F, et al. Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987 to 2001. Drug Alcohol Depend. 2006;82 (suppl 1):S29-S33.
20. Fuller CM, Ompad DC, Galea S, et al. Hepatitis C incidence - a comparison between injection and noninjection drug users in New York City. J Urban Health. 2004;81:20-24.
21. Kwiatkowski CF, Fortuin Corsi K, Booth RE. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction. 2002;97:1289-1294.
22. Hahn J, Page-Schafer K, Lum PJ, et al. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology. 2001;34:180-187.
23. Patrick DM, Tyndall MW, Cornelisse PGA. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. Can Med Assoc J. 2001;165:889-895.
24. Miller CL, Johnston C, Spittal PM, et al. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology. 2002;36:737-742.
25. Garten RJ, Lai S, Zhang J, et al. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol. 2004; 33:182.
26. Chawarski MC, Mazlan M, Schottenfeld RS. Heroin dependence and HIV infection in Malaysia. Drug Alcohol Depend. 2006;82(suppl 1):S39-S42.
27. Sarkar K, Bal B, Mukherjee R, et al. Epidemic of HIV coupled with hepatitis C virus among injecting drug users of Himalayan West Bengal, Eastern India, Bordering Nepal, Bhutan, and Bangladesh. Subst Use Misuse. 2006;41:341-352.
28. Shapatava E, Nelson KE, Tsertsvadze T, et al. Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia. Drug Alcohol Depend. 2006;82 (suppl 1):S35-S38.
29. Krupitsky EM, Zvartau EE, Lioznov DA, et al. Comorbidity of infectious and addictive diseases in St. Petersburg and the Leningrad Region, Russia. Eur Addict Res. 2006;12:12-19.
30. Van Beek I, Dwyer R, Dore GJ, et al. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ. 1998;17:433-437.
31. Rauch A, Rickenbach M, Weber R, et al. Swiss HIV Cohort Study. Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study. Clin Infect Dis. 2005;41:395-402. Epub ahead of print June 21, 2005.
32. Des Jarlais DC, Perlis T, Arasteh K, et al. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990 to 2001. AIDS. 2005;19(suppl 3):S20-S25.
33. Thorpe LE, Ouellet LJ, Hershow R, et al. Risk of hepatitis c virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002;155:645-653.
34. Department of Health. Hepatitis C Strategy for England. London: Department of Health; 2002.
35. Roseburg W. Screening and shouting about HCV. Gut. 2000;47:165-166.
36. Schechter MT, Strathdee SA, Cornelisse PG, et al. Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. AIDS. 1999;13:F45-F51.
37. Wright NM, Tompkins CN. A review of the evidence for the effectiveness of primary prevention interventions for Hepatitis C among injecting drug users. Harm Reduct J. 2006;3:27.
38. Vlahov D, Junge B. The role of needle exchange programs in HIV prevention. Public Health Rep. 1998;113(suppl 1):75-80.
39. Lurie P, Reingold AL, Bowser B, et al. The Public Health ImpactofNeedle Exchange Programsin the United States and Abroad. San Francisco (CA): University of California. Berkeley. School of Public Health. The Institute for Health Studies; 1993.
40. Stein MD, Anderson B, Charuvastra A, et al. A brief intervention for hazardous drinkers in a needle exchange program. J Subst Abuse Treatment. 2002; 22:23-31.
41. Kamb ML, Fishbein M, Douglas JM, et al. Efficacy of risk-reduction counselling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. JAMA. 1998;280: 1161-1167.
42. Gossop M, Marsden J, Stewart D. NTORS after five years: changes in substance use, health and criminal behaviour during the five years after intake. London: National Addiction Centre; 2001.
43. Selvey LA, Denton M, Plant AJ. Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: factors influencing hepatitis C serostatus. Aust N Zealand J Public Health. 1997;21:102-104.
44. Chamot E, de Saussure P, Hirschel B, et al. Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme. AIDS. 1992;6:430-431.
45. Crofts N, Nigro L, Oman K, et al. Methadone maintenance and hepatitis C virus infection among injecting drug users. Addiction. 1997;92: 999-1005.
46. Department of Health. Hepatitis C Action Plan for England. London: Department of Health; 2004.